viral vectors

AAV virus capsid
Biotech

Vertex discontinues AAV research for gene therapies

Despite the shift away from AAVs, a company spokesperson affirmed that Vertex’s “commitment to cell and genetic therapies remains strong.”
Darren Incorvaia May 2, 2025 6:22pm
Black phone dangling by cord in phonebooth

Ring lays off nearly half of staff, CEO to exit in new year

Dec 18, 2024 2:31pm
hepatitis B virus

GSK axes hepatitis B vaccine trial after missing efficacy goal

Dec 4, 2024 5:15am
A rainbow-colored viral vector containing a gene therapy against a background of rainbow-colored double-helix DNA

Ring's 'new class of viral vector' is re-dosable in primates

May 8, 2024 5:05pm
An artists impression of DNA The DNA appears to be made up of glowing orbs and appears on a blue background

Ring's new human viral vector delivers gene to retinas of mice

Apr 2, 2024 8:10am
gene therapy AAV adeno-associated viruses

ViroCell gets UK nod to produce viral vectors at London facility

Nov 2, 2023 9:50am